Literature DB >> 20065040

Estrogen receptors recruit SMRT and N-CoR corepressors through newly recognized contacts between the corepressor N terminus and the receptor DNA binding domain.

Natalia Varlakhanova1, Chelsea Snyder, Soumia Jose, Johnnie B Hahm, Martin L Privalsky.   

Abstract

Estrogen receptors (ERs) are hormone-regulated transcription factors that regulate key aspects of reproduction and development. ERs are unusual in that they do not typically repress transcription in the absence of hormone but instead possess otherwise cryptic repressive functions that are revealed upon binding to certain hormone antagonists. The roles of corepressors in the control of these aspects of ER function are complex and incompletely understood. We report here that ERs recruit SMRT through an unusual mode of interaction involving multiple contact surfaces. Two surfaces of SMRT, located at the N- and C-terminal domains, contribute to the recruitment of the corepressor to ERs in vitro and are crucial for the corepressor modulation of ER transcriptional activity in cells. These corepressor surfaces contact the DNA binding domain of the receptor, rather than the hormone binding domain previously elucidated for other corepressor/nuclear receptor interactions, and are modulated by the ER's recognition of cognate DNA binding sites. Several additional nuclear receptors, and at least one other corepressor, N-CoR, share aspects of this novel mode of corepressor recruitment. Our results highlight a molecular mechanism that helps explain several previously paradoxical aspects of ER-mediated transcriptional antagonism, which may have a broader significance for an understanding of target gene repression by other nuclear receptors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20065040      PMCID: PMC2832498          DOI: 10.1128/MCB.01002-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  77 in total

Review 1.  Coregulator codes of transcriptional regulation by nuclear receptors.

Authors:  M G Rosenfeld; C K Glass
Journal:  J Biol Chem       Date:  2001-07-17       Impact factor: 5.157

2.  Alternative mRNA splicing of SMRT creates functional diversity by generating corepressor isoforms with different affinities for different nuclear receptors.

Authors:  Michael L Goodson; Brian A Jonas; Martin L Privalsky
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

Review 3.  Nuclear receptors: one big family.

Authors:  Iain J McEwan
Journal:  Methods Mol Biol       Date:  2009

4.  Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors.

Authors:  S Sande; M L Privalsky
Journal:  Mol Endocrinol       Date:  1996-07

5.  The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.

Authors:  T A Jackson; J K Richer; D L Bain; G S Takimoto; L Tung; K B Horwitz
Journal:  Mol Endocrinol       Date:  1997-06

6.  Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes.

Authors:  Dipali Sharma; Neeraj K Saxena; Nancy E Davidson; Paula M Vertino
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

7.  The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs).

Authors:  P Webb; C M Anderson; C Valentine; P Nguyen; A Marimuthu; B L West; J D Baxter; P J Kushner
Journal:  Mol Endocrinol       Date:  2000-12

Review 8.  International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.

Authors:  Liliane Michalik; Johan Auwerx; Joel P Berger; V Krishna Chatterjee; Christopher K Glass; Frank J Gonzalez; Paul A Grimaldi; Takashi Kadowaki; Mitchell A Lazar; Stephen O'Rahilly; Colin N A Palmer; Jorge Plutzky; Janardan K Reddy; Bruce M Spiegelman; Bart Staels; Walter Wahli
Journal:  Pharmacol Rev       Date:  2006-12       Impact factor: 25.468

9.  Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT.

Authors:  Guoqing Liao; Liuh-Yow Chen; Aihua Zhang; Aparna Godavarthy; Fang Xia; Jagadish Chandra Ghosh; Hui Li; J Don Chen
Journal:  J Biol Chem       Date:  2002-11-18       Impact factor: 5.157

10.  The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.

Authors:  Theresa J Peterson; Sudipan Karmakar; Margaret C Pace; Tong Gao; Carolyn L Smith
Journal:  Mol Cell Biol       Date:  2007-06-25       Impact factor: 4.272

View more
  21 in total

Review 1.  General molecular biology and architecture of nuclear receptors.

Authors:  Michal Pawlak; Philippe Lefebvre; Bart Staels
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

2.  SMRTε, a corepressor variant, interacts with a restricted subset of nuclear receptors, including the retinoic acid receptors α and β.

Authors:  Brenda J Mengeling; Michael L Goodson; William Bourguet; Martin L Privalsky
Journal:  Mol Cell Endocrinol       Date:  2012-01-12       Impact factor: 4.102

3.  Alternative mRNA splicing of corepressors generates variants that play opposing roles in adipocyte differentiation.

Authors:  Michael L Goodson; Brenda J Mengeling; Brian A Jonas; Martin L Privalsky
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

4.  Structural insights into selective agonist actions of tamoxifen on human estrogen receptor alpha.

Authors:  Sandipan Chakraborty; Pradip Kumar Biswas
Journal:  J Mol Model       Date:  2014-07-25       Impact factor: 1.810

5.  Significance of estrogen receptor subtypes in breast tumorigenesis and progression.

Authors:  Weiliang Sun; Chijiang Gu; Minming Xia; Guoping Zhong; Haojun Song; Junming Guo
Journal:  Tumour Biol       Date:  2014-06-11

6.  Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cells.

Authors:  Grant Buchanan; Eleanor F Need; Jeffrey M Barrett; Tina Bianco-Miotto; Vanessa C Thompson; Lisa M Butler; Villis R Marshall; Wayne D Tilley; Gerhard A Coetzee
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

Review 7.  Nuclear receptor corepressor complexes in cancer: mechanism, function and regulation.

Authors:  Madeline M Wong; Chun Guo; Jinsong Zhang
Journal:  Am J Clin Exp Urol       Date:  2014-10-02

Review 8.  Nuclear receptor coregulators as a new paradigm for therapeutic targeting.

Authors:  Elaine Y Hsia; Michael L Goodson; June X Zou; Martin L Privalsky; Hong-Wu Chen
Journal:  Adv Drug Deliv Rev       Date:  2010-10-07       Impact factor: 15.470

9.  RXR agonist modulates TR: corepressor dissociation upon 9-cis retinoic acid treatment.

Authors:  Juliana Fattori; Jéssica L O Campos; Tábata R Doratioto; Lucas M Assis; Mariela T Vitorino; Igor Polikarpov; José Xavier-Neto; Ana Carolina M Figueira
Journal:  Mol Endocrinol       Date:  2014-12-26

10.  Neuronal activity controls the antagonistic balance between peroxisome proliferator-activated receptor-γ coactivator-1α and silencing mediator of retinoic acid and thyroid hormone receptors in regulating antioxidant defenses.

Authors:  Francesc X Soriano; Frédéric Léveillé; Sofia Papadia; Karen F S Bell; Clare Puddifoot; Giles E Hardingham
Journal:  Antioxid Redox Signal       Date:  2011-02-20       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.